Log In
Print this Print this


  Manage Alerts
Collapse Summary General Information
Company Aros Pharma ApS
DescriptionAcid-sensing ion channel subtype 1a (ASIC1a) inhibitor
Molecular Target Acid-sensing ion channel-1 (ASIC1)
Mechanism of Action 
Therapeutic ModalitySmall molecule
Latest Stage of DevelopmentPhase I
Standard IndicationPain
Indication DetailsTreat pain associated with irritable bowel syndrome (IBS)
Regulatory Designation

 Product Details
 Archive Items are loading loading
Collapse Summary Deals Information
 Deals Details
Get a free BioCentury trial today